BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3552315)

  • 1. Interpretation of changes in coronary flow that accompany pharmacologic interventions.
    Klocke FJ; Ellis AK; Canty JM
    Circulation; 1987 Jun; 75(6 Pt 2):V34-8. PubMed ID: 3552315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of two slow channel calcium entry blockers, FR 34235 and nifedipine, on true coronary collateral blood flow.
    Gross GJ; Warltier DC; Hardman HF
    J Cardiovasc Pharmacol; 1984; 6(1):61-7. PubMed ID: 6199613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium entry blockade on myocardial blood flow.
    Bache RJ
    Circulation; 1989 Dec; 80(6 Suppl):IV40-6. PubMed ID: 2557178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic vasodilators in the coronary circulation.
    Schwartz JS; Bache RJ
    Circulation; 1987 Jan; 75(1 Pt 2):I162-7. PubMed ID: 3791617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of calcium channel blockers on the coronary circulation.
    Cohn PF
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):299S-304S. PubMed ID: 2078316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol.
    Billinger M; Raeber L; Seiler C; Windecker S; Meier B; Hess OM
    Eur Heart J; 2004 Apr; 25(7):565-70. PubMed ID: 15120053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurements of intracoronary pressure and blood flow velocity].
    Seiler C; Fleisch M; Kaufmann U; Meier B
    Praxis (Bern 1994); 1997 Apr; 86(16):649-54. PubMed ID: 9221468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem.
    Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1984 Mar; 228(3):531-6. PubMed ID: 6707908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
    Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
    Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of furyl-dihydropyridine I on coronary collateral circulation in myocardial infarction of dogs].
    Jia MJ; Chen SL; Liao YL; Liu DQ; Li LS; Zhao NP
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):462-5. PubMed ID: 7717077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker.
    Kamezaki F; Tasaki H; Yamashita K; Shibata K; Hirakawa N; Tsutsui M; Kouzuma R; Nagatomo T; Adachi T; Otsuji Y
    Hypertens Res; 2007 Aug; 30(8):699-706. PubMed ID: 17917317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
    Ezra D; Boyd LM; Goldstein RE; Feuerstein G
    J Pharmacol Exp Ther; 1985 Apr; 233(1):229-34. PubMed ID: 3981457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
    Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of the action of different doses of panangin and isoptin on the collateral blood supply to the heart in coronarogenic myocardial lesion].
    Trifonov SA; Sapozhkov AV
    Farmakol Toksikol; 1982; 45(6):41-5. PubMed ID: 7151998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological basis of clinically used coronary hemodynamic indices.
    Spaan JA; Piek JJ; Hoffman JI; Siebes M
    Circulation; 2006 Jan; 113(3):446-55. PubMed ID: 16432075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Collateral coronary blood circulation and its role in the mechanism of the anti-ischemic (antianginal) action of pharmacologic preparations].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1989; 52(2):15-24. PubMed ID: 2663540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
    Nakaya H
    Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.